Paliperidone palmitate

CAS: 199739-10-1

Ref. 3D-FP26726

Produktinformation

• Name: Paliperidone palmitate
• Synonyme: 9-Hydroxyrisperidone palmitateInvega sustennaRO 92670, (9RS)-3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyrimidin-9-yl hexadecanoate, 9-Hydroxyrisperidone palmitate, Hexadecanoic acid, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido(1,2-a)pyrimidin-9-yl ester, Invega Sustenna, Paliperidone Palmitate [USAN], Ro 92670, Ro92670, Trevicta, Unii-R8P8Usm8Fr, Xeplion

Beschreibung

Paliperidone palmitate is a drug that is used in the treatment of schizophrenia. It is the most potent and selective atypical antipsychotic agent available. Paliperidone palmitate has shown long-term efficacy and low risk of extrapyramidal symptoms, which are associated with some other antipsychotic agents. The drug has been shown to have minimal effects on prolactin levels, although it can cause an increase in serum prolactin levels when administered with risperidone. Paliperidone palmitate is a prodrug that is metabolized by esterases to its active form, paliperidone. Paliperidone does not bind to plasma proteins and therefore may be more suitable for patients with hepatic impairment.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 664.89 g/mol
• Formel: C₃₉H₅₇FN₄O₄
• Reinheit: Min. 95%
• Farbe/Form: Powder